Long-term outcomes in children with glioblastoma: Clinical article

Journal of Neurosurgery: Pediatrics

Volumn 6, Issue 2, 2010, Pages 145-149

  Song, Kyung Sun ^a   Phi, Ji Hoon ^a   Cho, Byung Kyu ^a   Wang, Kyu Chang ^a   Lee, Ji Yeoun ^a   Kim, Dong Gyu ^a   Kim, Il Han ^a   Ahn, Hyo Seop ^a   Park, Sung Hye ^a   Kim, Seung Ki ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Glioblastoma; Outcome; Pediatric neurosurgery

Indexed keywords

TEMOZOLOMIDE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GLIOBLASTOMA; HUMAN; INFANT; LONG TERM CARE; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR BIOPSY;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; REOPERATION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77955298702     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2010.5.PEDS09558     Document Type: Article

References (21)

1. Barone G, Maurizi P, Tamburrini G, Riccardi R: Role of temozolomide in pediatric brain tumors. Childs Nerv Syst 22: 652-661, 2006
2. Campbell JW, Pollack IF, Martinez AJ, Shultz B: High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38:258-264, 1996
3. Chang SM, Barker FG II: Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer 104:1975-1984, 2005
4. Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, et al: Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16:1389-1396, 1989
5. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767-775, 1993
6. Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK: MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 48:403-407, 2007
7. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354, 2000
8. Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, et al: Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin Cancer Res 4:2383-2390, 1998
9. Finlay JL, Wisoff JH: The impact of extent of resection in the management of malignant gliomas of childhood. Childs Nerv Syst 15:786-788, 1999
10. Grossman SA, O'Neill A, Grunnet M, Mehta M, Pearlman JL, Wagner H, et al: Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21:1485-1491, 2003
11. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005
12. Hiesiger EM, Hayes RL, Pierz DM, Budzilovich GN: Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). J Neurooncol 16:93-104, 1993
13. Korshunov A, Golanov A, Sycheva R, Pronin I: Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J Clin Pathol 52:574-580, 1999
14. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al: Long-term survival with glioblastoma multiforme. Brain 130:2596-2606, 2007
15. Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227-235, 2004
16. Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, et al: Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery 50:1238-1245, 2002
17. Pope LZ, Serapião MJ, Serapião CJ, Oliveira MM, Benites Filho PR, Gugelmin ES, et al: [Pediatric glioblastoma: a clinicopathological study of 12 cases with p53 protein immunohistochemistry.] Arq Neuropsiquiatr 65 (4A):1056-1061, 2007 (Portuguese)
18. Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71:1-9, 1989
19. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
20. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
21. Zhu A, Shaeffer J, Leslie S, Kolm P, El-Mahdi AM: Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation. Int J Radiat Oncol Biol Phys 34:809-815, 1996